India · Delayed Price · Currency is INR NSE:INDRAMEDCO Statistics
Total Valuation
NSE:INDRAMEDCO has a market cap or net worth of INR 31.04 billion. The enterprise value is 28.78 billion.
| Market Cap | 31.04B |
| Enterprise Value | 28.78B |
Important Dates
The next estimated earnings date is Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Sep 18, 2026 |
Share Statistics
NSE:INDRAMEDCO has 91.67 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 91.67M |
| Shares Outstanding | 91.67M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 2.90% |
| Owned by Institutions (%) | 5.13% |
| Float | 40.08M |
Valuation Ratios
The trailing PE ratio is 16.51 and the forward PE ratio is 14.77.
| PE Ratio | 16.51 |
| Forward PE | 14.77 |
| PS Ratio | 2.04 |
| PB Ratio | 4.19 |
| P/TBV Ratio | 4.19 |
| P/FCF Ratio | 28.80 |
| P/OCF Ratio | 18.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.54, with an EV/FCF ratio of 26.70.
| EV / Earnings | 15.31 |
| EV / Sales | 1.89 |
| EV / EBITDA | 10.54 |
| EV / EBIT | 12.60 |
| EV / FCF | 26.70 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.34 |
| Interest Coverage | 37.38 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 32.98% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.66% |
| Revenue Per Employee | 5.08M |
| Profits Per Employee | 626,700 |
| Employee Count | 3,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:INDRAMEDCO has paid 645.20 million in taxes.
| Income Tax | 645.20M |
| Effective Tax Rate | 25.55% |
Stock Price Statistics
The stock price has decreased by -24.01% in the last 52 weeks. The beta is 0.43, so NSE:INDRAMEDCO's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -24.01% |
| 50-Day Moving Average | 365.11 |
| 200-Day Moving Average | 392.58 |
| Relative Strength Index (RSI) | 33.18 |
| Average Volume (20 Days) | 230,971 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:INDRAMEDCO had revenue of INR 15.24 billion and earned 1.88 billion in profits. Earnings per share was 20.51.
| Revenue | 15.24B |
| Gross Profit | 5.62B |
| Operating Income | 2.28B |
| Pretax Income | 2.53B |
| Net Income | 1.88B |
| EBITDA | 2.73B |
| EBIT | 2.28B |
| Earnings Per Share (EPS) | 20.51 |
Balance Sheet
The company has 2.63 billion in cash and 368.60 million in debt, with a net cash position of 2.26 billion or 24.70 per share.
| Cash & Cash Equivalents | 2.63B |
| Total Debt | 368.60M |
| Net Cash | 2.26B |
| Net Cash Per Share | 24.70 |
| Equity (Book Value) | 7.40B |
| Book Value Per Share | 80.78 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 1.67 billion and capital expenditures -596.50 million, giving a free cash flow of 1.08 billion.
| Operating Cash Flow | 1.67B |
| Capital Expenditures | -596.50M |
| Depreciation & Amortization | 445.20M |
| Net Borrowing | -24.30M |
| Free Cash Flow | 1.08B |
| FCF Per Share | 11.76 |
Margins
Gross margin is 36.86%, with operating and profit margins of 14.99% and 12.34%.
| Gross Margin | 36.86% |
| Operating Margin | 14.99% |
| Pretax Margin | 16.57% |
| Profit Margin | 12.34% |
| EBITDA Margin | 17.91% |
| EBIT Margin | 14.99% |
| FCF Margin | 7.27% |
Dividends & Yields
This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 1.18%.
| Dividend Per Share | 4.00 |
| Dividend Yield | 1.18% |
| Dividend Growth (YoY) | -11.11% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 34.02% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 1.19% |
| Earnings Yield | 6.06% |
| FCF Yield | 3.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |